| Code | Description | Claims | Beneficiaries | Total Paid |
|---|
| 99203 |
Office or other outpatient visit for the evaluation and management of a new patient, low complexity |
4,621 |
4,573 |
$232K |
| 87426 |
Infectious agent antigen detection, SARS-CoV-2 (COVID-19) |
2,729 |
2,648 |
$86K |
| 99383 |
|
859 |
850 |
$64K |
| 87880 |
Infectious agent antigen detection by immunoassay; Streptococcus, group A |
6,556 |
6,381 |
$59K |
| 99214 |
Office or other outpatient visit for the evaluation and management of an established patient, moderate complexity |
1,372 |
1,329 |
$58K |
| 87804 |
Infectious agent antigen detection by immunoassay; Influenza, each type |
5,275 |
2,577 |
$47K |
| 99204 |
Office or other outpatient visit for the evaluation and management of a new patient, moderate complexity |
603 |
597 |
$44K |
| 99384 |
|
2,714 |
2,411 |
$43K |
| 99213 |
Office or other outpatient visit for the evaluation and management of an established patient, low complexity |
1,338 |
1,286 |
$42K |
| 87811 |
Infectious agent antigen detection by immunoassay; SARS-CoV-2 (COVID-19) |
398 |
392 |
$11K |
| 99202 |
Office or other outpatient visit for the evaluation and management of a new patient, straightforward |
292 |
290 |
$9K |
| 99212 |
Office or other outpatient visit for the evaluation and management of an established patient, straightforward |
220 |
218 |
$4K |
| 92551 |
|
828 |
814 |
$4K |
| 99401 |
|
1,169 |
1,027 |
$882.00 |
| 99382 |
|
12 |
12 |
$850.82 |
| 96127 |
|
1,224 |
1,070 |
$682.50 |
| 96160 |
|
204 |
198 |
$182.96 |
| 96136 |
|
390 |
355 |
$180.53 |
| G8420 |
Bmi is documented within normal parameters and no follow-up plan is required |
1,847 |
1,650 |
$0.00 |
| G9903 |
Patient screened for tobacco use and identified as a tobacco non-user |
2,243 |
1,889 |
$0.00 |
| G8510 |
Screening for depression is documented as negative, a follow-up plan is not required |
1,126 |
965 |
$0.00 |
| G8418 |
Bmi is documented below normal parameters and a follow-up plan is documented |
16 |
15 |
$0.00 |
| G8417 |
Bmi is documented above normal parameters and a follow-up plan is documented |
1,518 |
1,369 |
$0.00 |
| 99173 |
|
663 |
646 |
$0.00 |
| G8431 |
Screening for depression is documented as being positive and a follow-up plan is documented |
326 |
298 |
$0.00 |
| S0119 |
Ondansetron, oral, 4 mg (for circumstances falling under the medicare statute, use hcpcs q code) |
123 |
114 |
$0.00 |